Monitoring of clinical safety of Yunnan baiyao capsules

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-17013923

Enrollment

Unknown

Registered

2017-12-14

Start date

2015-06-01

Completion date

Unknown

Last updated

2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Safety

Interventions

population of use Yunnan Baiyao capsules:Yunnan baiyao capsules

Eligibility

Sex/Gender

All

Age

2 Years to 90 Years

Inclusion criteria

Inclusion criteria: The patients who received the treatment of yunnan baiyao capsule were studied

Exclusion criteria

Exclusion criteria: contraindication in pregnancy

Design outcomes

Primary

Measure	Time frame
Adverse reaction;	—

Countries

China

Contacts

Public ContactWang Ningli

Tongren hospital

wningli@vip.163.com+86 13501136438

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026